Haitao Ren1, Yuan Li2, Chunmao Han1, Hang Hu1. 1. Department of Burns and Wound Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China. 2. Department of Ultrasound, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China. Electronic address: Docliyuan@126.com.
Abstract
BACKGROUND: Sepsis is one of the main causes of mortality in severe burns. However, it is difficult to diagnose early. Procalcitonin (PCT) has been reported as a biomarker for sepsis with controversial results. The aim of the study is to assess the diagnostic value of serum PCT for sepsis in burn patients through a meta-analysis of published studies. METHODS: A comprehensive literature search of PubMed, Embase, Web of Science and the Cochrane Library databases for studies published up to 1st March 2014 that evaluated PCT as a marker for diagnosing sepsis in burn patients was conducted. The summary receiver operating characteristic curves served to evaulate overall test performance. Meta-Disc 1.4 software and Stata 12.1 were used to analyze the data. RESULTS: A total of 566 patients (samples) from nine trials were identified and analyzed. The pooled sensitivity and specificity were 0.74 and 0.88, respectively. No threshold effect was found among studies. The area under the SROC curve (AUC) was 0.92. CONCLUSION: The results suggest that serum PCT is a useful biomarker (AUC=0.92) for early diagnosis of sepsis in burn patients. However, the results should be used with caution, because of obvious heterogeneity among those studies. Further large-scale research should regard more attention to the uniform cut-off value, and laboratories test methods.
BACKGROUND:Sepsis is one of the main causes of mortality in severe burns. However, it is difficult to diagnose early. Procalcitonin (PCT) has been reported as a biomarker for sepsis with controversial results. The aim of the study is to assess the diagnostic value of serum PCT for sepsis in burn patients through a meta-analysis of published studies. METHODS: A comprehensive literature search of PubMed, Embase, Web of Science and the Cochrane Library databases for studies published up to 1st March 2014 that evaluated PCT as a marker for diagnosing sepsis in burn patients was conducted. The summary receiver operating characteristic curves served to evaulate overall test performance. Meta-Disc 1.4 software and Stata 12.1 were used to analyze the data. RESULTS: A total of 566 patients (samples) from nine trials were identified and analyzed. The pooled sensitivity and specificity were 0.74 and 0.88, respectively. No threshold effect was found among studies. The area under the SROC curve (AUC) was 0.92. CONCLUSION: The results suggest that serum PCT is a useful biomarker (AUC=0.92) for early diagnosis of sepsis in burn patients. However, the results should be used with caution, because of obvious heterogeneity among those studies. Further large-scale research should regard more attention to the uniform cut-off value, and laboratories test methods.
Authors: R Schneider; M J Cohen; S Benenson; O Duchin; Y S Haviv; M Elhalel-Darnitski; P D Levin Journal: Intern Emerg Med Date: 2019-07-27 Impact factor: 3.397
Authors: Yee M Wong; Heather M LaPorte; Lauren J Albee; Todd A Baker; Harold H Bach; P Geoff Vana; Ann E Evans; Richard L Gamelli; Matthias Majetschak Journal: J Burn Care Res Date: 2017 Jan/Feb Impact factor: 1.845
Authors: Bong-Sung Kim; Christian Stoppe; Gerrit Grieb; Lin Leng; Maor Sauler; David Assis; David Simons; Arne Hendrick Boecker; Wibke Schulte; Marta Piecychna; Stephan Hager; Jürgen Bernhagen; Norbert Pallua; Richard Bucala Journal: Burns Date: 2016-05-18 Impact factor: 2.744
Authors: Juan J Egea-Guerrero; Carmen Martínez-Fernández; Ana Rodríguez-Rodríguez; Angélica Bohórquez-López; Angel Vilches-Arenas; María Pacheco-Sánchez; Juan M Guerrero; Francisco Murillo-Cabezas Journal: Plast Surg (Oakv) Date: 2015 Impact factor: 0.947